Irritable Bowel Syndrome Archives

4D Pharma and Merck Team to Develop Microbiome-based Vaccines

Biologics License Application (BLA), Business, Central Nervous System Diseases, Ebola, FDA, Gut, Irritable Bowel Syndrome, Live Biotherapeutics Vaccines, Microbiome, Partnerships, Solid Tumors

Leeds, UK-based 4D Pharma and Merck/MSD are developing Live Biotherapeutics vaccines, a new class of medicines.

October 8, 2019/by BioSpace

FDA Approves First-Ever Indication for Device for Patients With Functional Abdominal Pain Associated With IBS

Abdominal Pain, FDA, FDA/Regulatory, Irritable Bowel Syndrome, Medical Devices

Innovative Health Solutions Inc. announced FDA clearance for the new device IB-Stim to treat functional abdominal pain associated with irritable bowel syndrome (IBS) in patients ages 11-18 years old.

June 10, 2019/by Business Wire

For the 11th year, Med Ad News selected new Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.

December 12, 2018/by Joshua Slatko

Favorite DTC campaigns

Brands, CIC/IBS, DTC, Immuno-oncology, Irritable Bowel Syndrome, Issue Archives, June 2016, Lung Cancer, Marketing & Advertising, Sleep Disorders

Agency leaders talk about their favorite DTC campaigns of the past year.

June 8, 2016/by Administrator

Boehringer Ingelheim Will Invest 11 Billion Euros in Research and Development in the Next Five Years to Accelerate the Discovery of Next Generation Medical Breakthroughs

Biomedical, Cardimetabolic, Central Nervous System, Drug Discovery, Immunology, Innovation, Irritable Bowel Syndrome, Oncology, Partnership, Partnerships, R&D, Respiratory, Start-Ups, Start-ups, Startups

11 billion euro R&D programme through 2020, with 5 billion euro dedicated to pre-clinical R&D and 1.5 billion euro planned for cooperation with external partners New partnerships with the […]

November 11, 2015/by Business Wire